HEADER IMMUNE SYSTEM 19-JUL-13 3WFH TITLE CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAB FAB H FRAGMENT; COMPND 3 CHAIN: A; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: MAB FAB L FRAGMENT; COMPND 6 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL: HYBRIDOMA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_COMMON: MOUSE; SOURCE 9 ORGANISM_TAXID: 10090; SOURCE 10 CELL: HYBRIDOMA KEYWDS IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, FAB KEYWDS 2 FRAGMENT BY PAPAIN DIGESTION, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.SUGAHARA,H.AGO,H.SAINO,M.MIYANO REVDAT 3 13-NOV-24 3WFH 1 REMARK REVDAT 2 08-NOV-23 3WFH 1 REMARK REVDAT 1 23-JUL-14 3WFH 0 JRNL AUTH M.SUGAHARA,H.AGO,H.SAINO,M.MIYANO,Y.KURAHASHI,S.AOYAMA, JRNL AUTH 2 M.TAKEHIRA,K.YUTANI,S.YAMAMOTO JRNL TITL CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT WITH JRNL TITL 2 PROSTAGLANDIN E2 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 38569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.1360 - 4.0915 1.00 3888 187 0.1546 0.1570 REMARK 3 2 4.0915 - 3.2483 1.00 3714 194 0.1501 0.2005 REMARK 3 3 3.2483 - 2.8379 1.00 3676 189 0.1682 0.1866 REMARK 3 4 2.8379 - 2.5785 1.00 3649 200 0.1792 0.2197 REMARK 3 5 2.5785 - 2.3937 1.00 3620 226 0.1792 0.2280 REMARK 3 6 2.3937 - 2.2526 1.00 3634 179 0.1790 0.1925 REMARK 3 7 2.2526 - 2.1398 1.00 3648 186 0.1736 0.2364 REMARK 3 8 2.1398 - 2.0467 1.00 3619 177 0.1734 0.1894 REMARK 3 9 2.0467 - 1.9679 1.00 3605 183 0.1800 0.2135 REMARK 3 10 1.9679 - 1.9000 1.00 3588 207 0.2014 0.2602 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3436 REMARK 3 ANGLE : 1.006 4690 REMARK 3 CHIRALITY : 0.069 530 REMARK 3 PLANARITY : 0.005 601 REMARK 3 DIHEDRAL : 12.415 1200 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED ALSO REFMAC5 REMARK 3 AND CNS. REMARK 4 REMARK 4 3WFH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000096269. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) DOUBL CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38574 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 35.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.40600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2DDQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30%(W/V) PEG 4000, 0.2M AMMONIUM REMARK 280 SULFATE, 0.1M NA-CITRATE, PH 6.0, OIL MICROBATCH, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.37000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.26500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.37000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.26500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 132 REMARK 465 ALA A 133 REMARK 465 ALA A 134 REMARK 465 GLN A 135 REMARK 465 THR A 136 REMARK 465 ASN A 137 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 1 CE NZ REMARK 470 GLN A 5 CD OE1 NE2 REMARK 470 LYS A 65 CD CE NZ REMARK 470 LYS A 119 CD CE NZ REMARK 470 GLN A 175 CG CD OE1 NE2 REMARK 470 SER A 176 OG REMARK 470 ARG B 24 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 75 CG OD1 OD2 REMARK 470 LYS B 112 CD CE NZ REMARK 470 SER B 127 OG REMARK 470 LYS B 147 CD CE NZ REMARK 470 LYS B 152 CD CE NZ REMARK 470 ASN B 162 CG OD1 ND2 REMARK 470 LYS B 174 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 456 O HOH A 555 1.81 REMARK 500 O HOH A 605 O HOH A 611 1.98 REMARK 500 O HOH A 459 O HOH A 594 1.98 REMARK 500 O HOH B 589 O HOH B 612 1.99 REMARK 500 O HOH B 562 O HOH B 619 1.99 REMARK 500 O GLY B 133 O HOH B 600 2.01 REMARK 500 O HOH A 484 O HOH B 525 2.06 REMARK 500 O HOH A 587 O HOH A 600 2.07 REMARK 500 OG1 THR B 198 OG SER B 213 2.12 REMARK 500 O HOH A 481 O HOH A 609 2.12 REMARK 500 OG SER B 206 O SER B 208 2.12 REMARK 500 O GLY B 73 O HOH B 494 2.14 REMARK 500 O HOH B 609 O HOH B 644 2.15 REMARK 500 O HOH B 533 O HOH B 586 2.15 REMARK 500 O LYS A 74 O HOH A 508 2.16 REMARK 500 O HOH B 633 O HOH B 642 2.16 REMARK 500 NE2 GLN A 109 O HOH A 434 2.18 REMARK 500 O HOH B 590 O HOH B 598 2.18 REMARK 500 O PRO A 130 O HOH A 447 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 177 -5.04 72.89 REMARK 500 VAL B 56 -53.76 71.57 REMARK 500 ARG B 82 78.05 73.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P2E B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3WE6 RELATED DB: PDB REMARK 900 PGE2MAB FAB WITH NO LIGAND REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE REFERENCE SEQUENCE OF CHAIN A IS BAL50003 AND CHAIN B IS REMARK 999 BAL50004 IN GENBANK. DBREF 3WFH A 1 217 PDB 3WFH 3WFH 1 217 DBREF 3WFH B 1 216 PDB 3WFH 3WFH 1 216 SEQRES 1 A 217 LYS VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL LYS SEQRES 2 A 217 PRO GLY ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 A 217 TYR THR PHE THR GLU TYR PHE ILE HIS TRP VAL LYS GLN SEQRES 4 A 217 ARG SER GLY GLN GLY LEU GLU TRP ILE GLY TRP PHE TYR SEQRES 5 A 217 PRO GLY SER GLY SER LEU ASN TYR ASN GLY LYS PHE LYS SEQRES 6 A 217 ASP LYS ALA THR PHE THR ALA ASP LYS SER SER SER THR SEQRES 7 A 217 VAL TYR LEU GLU LEU SER ARG LEU THR SER GLU ASP SER SEQRES 8 A 217 ALA VAL TYR PHE CYS ALA SER HIS ALA TYR ASP LYS GLU SEQRES 9 A 217 PRO TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER ALA SEQRES 10 A 217 ALA LYS THR THR PRO PRO SER VAL TYR PRO LEU ALA PRO SEQRES 11 A 217 GLY SER ALA ALA GLN THR ASN SER MET VAL THR LEU GLY SEQRES 12 A 217 CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR VAL SEQRES 13 A 217 THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR SEQRES 14 A 217 PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SEQRES 15 A 217 SER SER VAL THR VAL PRO SER SER THR TRP PRO SER GLU SEQRES 16 A 217 THR VAL THR CYS ASN VAL ALA HIS PRO ALA SER SER THR SEQRES 17 A 217 LYS VAL ASP LYS LYS ILE VAL PRO ARG SEQRES 1 B 216 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 B 216 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 B 216 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 B 216 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 B 216 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 B 216 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 B 216 LYS ILE ASN ARG VAL GLU ALA GLU ASP LEU GLY ILE TYR SEQRES 8 B 216 TYR CYS LEU GLN GLY SER HIS VAL PRO LEU THR PHE GLY SEQRES 9 B 216 ALA GLY THR THR LEU GLU LEU LYS ARG ALA ASP ALA ALA SEQRES 10 B 216 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 B 216 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 B 216 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 B 216 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 B 216 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 B 216 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 B 216 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 B 216 PRO ILE VAL LYS SER PHE ASN ARG HET P2E B 301 25 HETNAM P2E (Z)-7-[(1R,2R,3R)-3-HYDROXY-2-[(E,3S)-3-HYDROXYOCT-1- HETNAM 2 P2E ENYL]-5-OXO-CYCLOPENTYL]HEPT-5-ENOIC ACID HETSYN P2E PROSTAGLANDIN E2 FORMUL 3 P2E C20 H32 O5 FORMUL 4 HOH *571(H2 O) HELIX 1 1 THR A 28 TYR A 32 5 5 HELIX 2 2 GLY A 62 LYS A 65 5 4 HELIX 3 3 THR A 87 SER A 91 5 5 HELIX 4 4 SER A 160 SER A 162 5 3 HELIX 5 5 PRO A 204 SER A 207 5 4 HELIX 6 6 GLU B 84 LEU B 88 5 5 HELIX 7 7 SER B 126 SER B 132 1 7 HELIX 8 8 LYS B 188 GLU B 192 1 5 SHEET 1 A 4 GLN A 3 GLN A 6 0 SHEET 2 A 4 VAL A 18 SER A 25 -1 O LYS A 23 N GLN A 5 SHEET 3 A 4 THR A 78 LEU A 83 -1 O LEU A 81 N LEU A 20 SHEET 4 A 4 ALA A 68 ASP A 73 -1 N THR A 71 O TYR A 80 SHEET 1 B 6 GLU A 10 VAL A 12 0 SHEET 2 B 6 THR A 111 VAL A 115 1 O LEU A 112 N GLU A 10 SHEET 3 B 6 ALA A 92 HIS A 99 -1 N ALA A 92 O VAL A 113 SHEET 4 B 6 PHE A 33 GLN A 39 -1 N PHE A 33 O HIS A 99 SHEET 5 B 6 GLU A 46 PHE A 51 -1 O GLU A 46 N LYS A 38 SHEET 6 B 6 LEU A 58 TYR A 60 -1 O ASN A 59 N TRP A 50 SHEET 1 C 4 GLU A 10 VAL A 12 0 SHEET 2 C 4 THR A 111 VAL A 115 1 O LEU A 112 N GLU A 10 SHEET 3 C 4 ALA A 92 HIS A 99 -1 N ALA A 92 O VAL A 113 SHEET 4 C 4 TYR A 106 TRP A 107 -1 O TYR A 106 N SER A 98 SHEET 1 D 4 SER A 124 LEU A 128 0 SHEET 2 D 4 MET A 139 TYR A 149 -1 O LEU A 145 N TYR A 126 SHEET 3 D 4 LEU A 178 PRO A 188 -1 O LEU A 181 N VAL A 146 SHEET 4 D 4 VAL A 167 THR A 169 -1 N HIS A 168 O SER A 184 SHEET 1 E 4 SER A 124 LEU A 128 0 SHEET 2 E 4 MET A 139 TYR A 149 -1 O LEU A 145 N TYR A 126 SHEET 3 E 4 LEU A 178 PRO A 188 -1 O LEU A 181 N VAL A 146 SHEET 4 E 4 VAL A 173 GLN A 175 -1 N GLN A 175 O LEU A 178 SHEET 1 F 3 THR A 155 TRP A 158 0 SHEET 2 F 3 THR A 198 HIS A 203 -1 O ASN A 200 N THR A 157 SHEET 3 F 3 THR A 208 LYS A 213 -1 O VAL A 210 N VAL A 201 SHEET 1 G 4 MET B 4 THR B 7 0 SHEET 2 G 4 GLN B 18 SER B 25 -1 O ARG B 24 N THR B 5 SHEET 3 G 4 ASP B 75 ASN B 81 -1 O LEU B 78 N ILE B 21 SHEET 4 G 4 PHE B 67 SER B 72 -1 N SER B 68 O LYS B 79 SHEET 1 H 6 SER B 10 VAL B 13 0 SHEET 2 H 6 THR B 107 LEU B 111 1 O THR B 108 N LEU B 11 SHEET 3 H 6 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 107 SHEET 4 H 6 LEU B 38 GLN B 43 -1 N GLN B 43 O ILE B 90 SHEET 5 H 6 LYS B 50 TYR B 54 -1 O LEU B 52 N TRP B 40 SHEET 6 H 6 ASN B 58 ARG B 59 -1 O ASN B 58 N TYR B 54 SHEET 1 I 4 SER B 10 VAL B 13 0 SHEET 2 I 4 THR B 107 LEU B 111 1 O THR B 108 N LEU B 11 SHEET 3 I 4 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 107 SHEET 4 I 4 THR B 102 PHE B 103 -1 O THR B 102 N GLN B 95 SHEET 1 J 4 THR B 119 PHE B 123 0 SHEET 2 J 4 GLY B 134 PHE B 144 -1 O PHE B 140 N SER B 121 SHEET 3 J 4 TYR B 178 THR B 187 -1 O LEU B 184 N VAL B 137 SHEET 4 J 4 VAL B 164 TRP B 168 -1 N SER B 167 O SER B 181 SHEET 1 K 4 SER B 158 ARG B 160 0 SHEET 2 K 4 ASN B 150 ILE B 155 -1 N ILE B 155 O SER B 158 SHEET 3 K 4 SER B 196 THR B 202 -1 O GLU B 200 N LYS B 152 SHEET 4 K 4 ILE B 210 ASN B 215 -1 O ILE B 210 N ALA B 201 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 2 CYS A 144 CYS A 199 1555 1555 2.03 SSBOND 3 CYS B 23 CYS B 93 1555 1555 2.06 SSBOND 4 CYS B 139 CYS B 199 1555 1555 2.04 CISPEP 1 PHE A 150 PRO A 151 0 -5.95 CISPEP 2 GLU A 152 PRO A 153 0 1.77 CISPEP 3 TRP A 192 PRO A 193 0 5.80 CISPEP 4 THR B 7 PRO B 8 0 -2.94 CISPEP 5 VAL B 99 PRO B 100 0 0.32 CISPEP 6 TYR B 145 PRO B 146 0 0.88 SITE 1 AC1 13 LYS A 13 PRO A 14 PHE A 33 HIS A 99 SITE 2 AC1 13 ASP A 102 PRO A 105 HOH A 313 HOH A 477 SITE 3 AC1 13 HIS B 31 TYR B 37 GLU B 39 GLY B 96 SITE 4 AC1 13 HOH B 561 CRYST1 70.260 82.530 82.740 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012117 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012086 0.00000